UBS Group’s ETRACS Quarterly Pay 1.5x Leveraged MarketVector BDC Liquid Index ETN due Jun 10 2050 BDCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Buy
61,100
+13,100
+27% +$289K ﹤0.01% 5376
2025
Q4
$1.17M Buy
48,000
+47,984
+299,900% +$1.15M ﹤0.01% 5438
2025
Q3
$409 Buy
+16
New +$452 ﹤0.01% 9692
2024
Q3
Sell
-73
Closed -$2.49K 9503
2024
Q2
$2.49K Buy
73
+44
+152% +$1.48K ﹤0.01% 8350
2024
Q1
$981 Buy
+29
New +$942 ﹤0.01% 8281
2022
Q4
Sell
-40
Closed -$1K 10727
2022
Q3
$1K Sell
40
-835
-95% -$27.2K ﹤0.01% 9927
2022
Q2
$27K Buy
+875
New +$31.3K ﹤0.01% 6498
2020
Q4
Sell
-200
Closed -$5K 8380
2020
Q3
$5K Buy
+200
New +$4.88K ﹤0.01% 7288

UBS Group's BDCX Position: Q1 2026 in Review

UBS Group increased its ETRACS Quarterly Pay 1.5x Leveraged MarketVector BDC Liquid Index ETN due Jun 10 2050 (BDCX) stake by 27% in Q1 2026, buying an estimated $289K and bringing the position to 61,100 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #5376.

UBS Group first reported a position in BDCX in Q3 2020 and has held it in 8 quarters since. 1 fund tracked by Wall St. Rank holds BDCX as of Q1 2026.

  • UBS Group held 61,100 shares of ETRACS Quarterly Pay 1.5x Leveraged MarketVector BDC Liquid Index ETN due Jun 10 2050 worth $1.25M as of Q1 2026.
  • UBS Group bought 13,100 ETRACS Quarterly Pay 1.5x Leveraged MarketVector BDC Liquid Index ETN due Jun 10 2050 shares in Q1 2026, an estimated $289K.
  • ETRACS Quarterly Pay 1.5x Leveraged MarketVector BDC Liquid Index ETN due Jun 10 2050 made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5376 holding.
  • UBS Group first reported a position in ETRACS Quarterly Pay 1.5x Leveraged MarketVector BDC Liquid Index ETN due Jun 10 2050 in Q3 2020 and has held it in 8 quarters since.
  • 1 fund tracked by Wall St. Rank held ETRACS Quarterly Pay 1.5x Leveraged MarketVector BDC Liquid Index ETN due Jun 10 2050 as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.